FDA Wants More Data on Neffy, First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray...
Source: Drugs.com - Daily MedNews - September 20, 2023 Category: General Medicine Source Type: news

Study Looks at Treatment Patterns for Alopecia Areata
WEDNESDAY, Sept. 20, 2023 -- For patients with alopecia areata (AA), corticosteroids are the most commonly used treatment, and by one year, 71.8 percent are receiving no treatment, according to a study published online Sept. 20 in JAMA...
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth
WEDNESDAY, Sept. 20, 2023 -- For adolescents and young adults diagnosed with ulcerative colitis (UC), the rate of discontinuation of 5-aminosalicylic acid (5-ASA) maintenance treatment is high within the first year, according to a study published...
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

Practice Points Developed for Treatment of Outpatient COVID-19
WEDNESDAY, Sept. 20, 2023 -- In an updated clinical guideline issued by the American College of Physicians and published online Sept. 19 in the Annals of Internal Medicine, living, rapid practice points are presented for the outpatient treatment of...
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

Ivani ’s genetic disease is worsening as she ages. Her mother hopes Australia’s new biobank will help
Exclusive: National Muscle Disease Bio-databank will store blood test and skin biopsy samples from children with diseases such as muscular dystrophyFollow our Australia news live blog for latest updatesGet ourmorning and afternoon news emails,free app ordaily news podcastBindu Shree remembers her daughter Ivani had “such a nice plump face as a baby”, but now she sees gravity pulling down her four-year-old’s cheeks as the muscles in her face become weaker.When Ivani was diagnosed with a genetic muscle disease at four months, Shree ’s first response was to ask the doctors, “What’s the treatment? What can we do to...
Source: Guardian Unlimited Science - September 20, 2023 Category: Science Authors: Natasha May Tags: Health Australia news Children's health Medical research Source Type: news

EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study EpiPen Nasal Spray Suffers Setback as FDA Seeks Fresh Study
The regulator has declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions.Reuters Health Information
Source: Medscape Allergy Headlines - September 20, 2023 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news

' Nopioids ' for Chronic Pain: Only When Nothing Else Works ' Nopioids ' for Chronic Pain: Only When Nothing Else Works
Dr Neha Pathak interviews Dr Daniel Clauw about how opioids fit into the treatment armamentarium when managing chronic pain.Medscape Internal Medicine
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Shortage of treatment for highly contagious itchy skin condition caused by tiny mites poses 'significant threat' to public health, UK health leaders warn
A shortage of key medications that treat scabies a highly contagious skin condition is a major threat senior UK dermatologists warn as they urge the Government to act to boost supplies.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

FDA refuses to okay first nasal spray for allergic reactions, firm says
It would have been the first needle-free treatment for serious allergic reactions triggered by certain foods, insect stings and medications.
Source: Washington Post: To Your Health - September 20, 2023 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Namibia: Breast Cancer, the Second-Most Common Cancer in Namibia
[Namibian] Breast cancer has affected the lives of countless Namibian women and their families, but Namibians are determined to improve breast cancer awareness, early detection, and treatment.
Source: AllAfrica News: Health and Medicine - September 20, 2023 Category: African Health Tags: Health and Medicine Namibia Noncommunicable Diseases Southern Africa Source Type: news

Researchers discover biomarker for tracking depression recovery
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Source: National Institutes of Health (NIH) News Releases - September 20, 2023 Category: American Health Source Type: news

Uganda: MSF Ends Support to HIV Programme in Arua After More Than 20 Years
[MSF] For over 20 years, Médecins Sans Frontières (MSF) has supported the Ministry of Health with treatment for people living with HIV/AIDS in the West Nile region of Uganda and more specifically, in the Arua district.
Source: AllAfrica News: Health and Medicine - September 20, 2023 Category: African Health Tags: Aid and Assistance HIV-Aids and STDs East Africa External Relations Health and Medicine International Organizations and Africa NGOs and Civil Society Uganda Source Type: news

The Man Who Thinks He Can Live Forever
In a neat little neighborhood in Venice, Calif., there’s a block of squat, similar homes, filled with mortals spending their finite days on the planet eating pizza with friends, blowing out candles on birthday cakes, and binging late-night television. Halfway down the street, there’s a cavernous black modern box. This is where Bryan Johnson is working on what he calls “the most significant revolution in the history of Homo sapiens.”  [time-brightcove not-tgx=”true”] Johnson, 46, is a centimillionaire tech entrepreneur who has spent most of the last three years in pursuit of a si...
Source: TIME: Health - September 20, 2023 Category: Consumer Health News Authors: Charlotte Alter Tags: Uncategorized feature Source Type: news

Dynamic Risk Assessment for HCC in Patients With Chronic HCV Dynamic Risk Assessment for HCC in Patients With Chronic HCV
The authors developed a model for identifying hepatocellular carcinoma risk factors in individuals with chronic HCV, across antiviral treatment status and interactions with cirrhosis.Journal of Viral Hepatitis
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA declines to approve first needle-free option to EpiPen
Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS Pharmaceuticals, to conduct further testing.
Source: Health News - UPI.com - September 20, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20